RxDoctor Payments Data

Ayoosh Pareek, MD

Orthopaedic Surgery · New York, NYNPI 1669904728

Payments from drug & device makers

$56,476in general payments, 2019–2025

Across 66 payments — averaging $855.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$30K
  • Arthrex$19K
  • Stryker$4K
  • Newclip USA LLC$3K
  • Johnson & Johnson$261
  • Moximed, Inc$211
  • plus $428 from 3 others

What the payments were for

  • Grants$23,92942%
  • Travel & lodging$7,97014%
  • Food & beverage$3,7927%
  • Education$20,78637%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew13$30,469
Arthrex23$18,540
Stryker18$3,711
Newclip USA LLC2$2,855
Johnson & Johnson3$261
Moximed, Inc2$211
Linvatec Corporation1$166
Suvon Surgical LLC3$150
Bodycad USA Corp1$112

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$56,476 in reported general payments places this provider in the 80th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York

Medicare billing

Part B allowed, 2024
$3,374
Medicare patients
18
Services billed
30

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →